Product NDC: | 16590-740 |
Proprietary Name: | KADIAN |
Non Proprietary Name: | MORPHINE SULFATE |
Active Ingredient(s): | 100 mg/1 & nbsp; MORPHINE SULFATE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-740 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020616 |
Marketing Category: | NDA |
Start Marketing Date: | 20090407 |
Package NDC: | 16590-740-90 |
Package Description: | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-740-90) |
NDC Code | 16590-740-90 |
Proprietary Name | KADIAN |
Package Description | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-740-90) |
Product NDC | 16590-740 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MORPHINE SULFATE |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20090407 |
Marketing Category Name | NDA |
Labeler Name | STAT RX USA LLC |
Substance Name | MORPHINE SULFATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |